We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$502M
AUM Growth
-$19.7M
Cap. Flow
-$28.5M
Cap. Flow %
-5.67%
Top 10 Hldgs %
46.7%
Holding
85
New
Increased
52
Reduced
19
Closed
4

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.2M
2
CRM icon
Salesforce
CRM
+$6.89M
3
BABA icon
Alibaba
BABA
+$6.08M
4
AAPL icon
Apple
AAPL
+$5.65M
5
XYZ
Block Inc
XYZ
+$4.44M

Sector Composition

Rank Sector Weight
1 Healthcare 34.2%
2 Technology 19.72%
3 Financials 11.77%
4 Consumer Discretionary 10.05%
5 Communication Services 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$37M 7.38%
303,242
-44,001
-13% -$5.65M
ISRG icon
2
Intuitive Surgical
ISRG
$121B
$35.3M 7.03%
143,331
-5,070
-3% -$1.28M
MA icon
3
Mastercard
MA
$477B
$26.8M 5.34%
75,318
-2,436
-3% -$850K
ABMD
4
DELISTED
Abiomed Inc
ABMD
$26.3M 5.23%
82,466
+2,152
+3% +$689K
XYZ
5
Block Inc
XYZ
$45.9B
$24.2M 4.83%
106,720
-19,001
-15% -$4.44M
IDXX icon
6
Idexx Laboratories
IDXX
$42.9B
$22.9M 4.56%
46,796
-4,677
-9% -$2.34M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.91T
$20.7M 4.12%
200,420
-18,820
-9% -$1.86M
BBBY
8
DELISTED
Bed Bath & Beyond Inc
BBBY
$14.6M 2.91%
500,515
+151,515
+43% +$4.24M
ADBE icon
9
Adobe
ADBE
$89.5B
$13.7M 2.74%
28,917
-795
-3% -$372K
JPM icon
10
JPMorgan Chase
JPM
$939B
$12.9M 2.57%
84,932
-2,437
-3% -$351K
EXAS
11
DELISTED
Exact Sciences
EXAS
$12.7M 2.54%
96,686
+7,558
+8% +$1.03M
ILMN icon
12
Illumina
ILMN
$29.4B
$12.2M 2.43%
32,698
-283
-0.9% -$115K
LOW icon
13
Lowe's Companies
LOW
$116B
$10.8M 2.16%
56,928
-1,075
-2% -$184K
MSFT icon
14
Microsoft
MSFT
$2.84T
$10.7M 2.14%
45,425
-625
-1% -$145K
SIVB
15
DELISTED
SVB Financial Group
SIVB
$10.6M 2.11%
21,504
+345
+2% +$170K
EW icon
16
Edwards Lifesciences
EW
$47.6B
$10.2M 2.04%
122,232
-6,879
-5% -$582K
RETA
17
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$10.1M 2.01%
101,204
-12,488
-11% -$1.46M
PG icon
18
Procter & Gamble
PG
$343B
$8.64M 1.72%
63,791
+685
+1% +$89.4K
XOM icon
19
ExxonMobil
XOM
$651B
$8.02M 1.6%
141,468
+3,975
+3% +$208K
MCD icon
20
McDonald's
MCD
$188B
$7.2M 1.43%
31,936
+702
+2% +$150K
ABBV icon
21
AbbVie
ABBV
$458B
$7.05M 1.4%
65,123
-104
-0.2% -$11.1K
TEAM icon
22
Atlassian
TEAM
$22B
$6.95M 1.38%
32,986
+30
+0.1% +$6.98K
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$121B
$6.88M 1.37%
32,026
-37,342
-54% -$8.2M
JNJ icon
24
Johnson & Johnson
JNJ
$635B
$6.86M 1.37%
41,514
+1,768
+4% +$286K
TFC icon
25
Truist Financial
TFC
$63.2B
$6.8M 1.35%
115,748
+3,393
+3% +$186K

Similar funds

Biondo Investment Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Biondo Investment Advisors held 85 positions worth $502M, down 3.8% from $522M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Biondo Investment Advisors withdrew a net $28.5M in Q1 2021, closing 4 positions and reducing 19 holdings. Its most notable exit was Salesforce, an estimated $6.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors added an estimated $4.24M to Bed Bath & Beyond Inc.

  • Biondo Investment Advisors added most to Bed Bath & Beyond Inc in Q1 2021, an estimated $4.24M increase.
  • Biondo Investment Advisors's biggest Q1 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $8.2M.
  • Biondo Investment Advisors fully exited Salesforce in Q1 2021, selling an estimated $6.89M.
  • Biondo Investment Advisors's ten largest holdings make up 47% of its $502M portfolio in Q1 2021.
  • Biondo Investment Advisors opened 0 new positions and closed 4 in Q1 2021.
  • Biondo Investment Advisors's portfolio value fell 3.8% quarter-over-quarter to $502M.

Based on Biondo Investment Advisors's 13F filing for Q1 2021, filed 11 May 2021.